Form 4: Microbot Medical Inc. Director Acquires Stock Options
SEC Form 4
Scott R. Burell, a director of Microbot Medical Inc., acquired stock options exercisable for 10,000 shares on January 28, 2025.
Summary
- On January 28, 2025, Scott R. Burell, a director of Microbot Medical Inc., reported a transaction involving the acquisition of stock options.
- The transaction involved the acquisition of options to purchase 10,000 shares of Microbot Medical Inc.'s common stock at an exercise price of $1.93 per share.
- These options are exercisable from December 17, 2025, and expire on January 28, 2035.
- Following the reported transaction, Burell directly owns 10,000 derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of a stock option grant to a director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and provides insight into the compensation structure for board members at Microbot Medical Inc.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.
Key Dates
| Date | Description |
|---|---|
| 01/28/2025 | Date of earliest transaction: Scott Burell acquired stock options. |
| 01/28/2025 | Transaction Date: Scott Burell acquired stock options. |
| 12/17/2025 | Date Exercisable: Stock options become exercisable. |
| 01/28/2035 | Expiration Date: Stock options expire. |
| 01/29/2025 | Signature Date: Form 4 signed by Scott Burell. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.